ENZN
Enzon Pharmaceuticals, Inc.
0.0500
+0.0000+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q1 '26)

No earnings call transcript available yet

Last Quarter (Q4 '25)

No earnings call transcript available

Key Stats

Market Cap
3.71M
P/E (TTM)
-
Basic EPS (TTM)
-0.05
Dividend Yield
0%

Recent Filings

About 

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

CEO
Mr. Richard L. Feinstein CPA
IPO
2/15/1984
Website
https://enzon.com
Sector
Healthcare
Industry
Biotechnology

Related Companies  

BZYR
Burzynski Research Institute, I
0.03-0.00
ELVN
Enliven Therapeutics, Inc.
16.91-0.26
ENDV
Endonovo Therapeutics, Inc.
0.00+0.00
ENGN
enGene Holdings Inc.
8.38-0.05
ENTA
Enanta Pharmaceuticals, Inc.
14.85-0.02
ETNB
89bio, Inc.
14.84+0.00
EXOZ
eXoZymes Inc.
12.52-1.78
LENZ
LENZ Therapeutics, Inc.
16.70-0.38
NBY
NovaBay Pharmaceuticals, Inc.
3.16+0.45
TTNP
Titan Pharmaceuticals, Inc.
4.61-0.18